Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HCM Relative to the S&P 500

HCM Relative to the Sector

Seasonal Chart Analysis

Analysis of the Hutchison China MediTech Ltd. ADS (NASD:HCM) seasonal charts above shows that a Buy Date of May 25 and a Sell Date of August 13 has resulted in a geometric average return of 13.09% above the benchmark rate of the S&P 500 Total Return Index over the past 8 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 8 years by an average of 26.21% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 8 years of data is available for shares of HCM, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

To download HCM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: HCM